Berger, Carola <br/><br/>
Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.  [electronic resource] 

 -  Gastroenterology  Nov 2014 
 - 1094-105.e25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2014.07.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--chemistry<br/>Binding Sites<br/>Carbamates<br/>Cell Line, Tumor<br/>Cell Membrane--drug effects<br/>Drug Design<br/>Drug Resistance, Viral<br/>Hepacivirus--drug effects<br/>Hepatocytes--drug effects<br/>Host-Pathogen Interactions<br/>Humans<br/>Imidazoles--chemistry<br/>Minor Histocompatibility Antigens<br/>Molecular Docking Simulation<br/>Molecular Structure<br/>Mutation<br/>Phosphotransferases (Alcohol Group Acceptor)--metabolism<br/>Protease Inhibitors--chemistry<br/>Protein Conformation<br/>Protein Multimerization<br/>Pyrrolidines<br/>Structure-Activity Relationship<br/>Time Factors<br/>Transfection<br/>Valine--analogs & derivatives<br/>Viral Nonstructural Proteins--antagonists & inhibitors<br/>Virus Replication--drug effects